Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia
Effect of Leveraging Community-level Structures to Strengthen Prevention, Screening and Treatment of Severe Acute Malnutrition in Ethiopia
- Acute Malnutrition, Severe
- Malnutrition, Child
- Wasting
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- International Food Policy Research Institute
- Enrolment target
- 1,080
- Started
- 2 May 2024
- Main results due
- 30 September 2026
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Ages 6 months to 5 years.
- Open to any sex.
- Healthy volunteers can take part.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Child 6-59 months of age * Suffering from SAM (defined as MUAC \< 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score \<-3) OR currently enrolled in SAM OTP Exclusion Criteria: \- Anthropometric malformation or being handicapped which hampers anthropometric measurements.
What this study is about
In the sponsor’s own words, from the registry.
The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.
Study sites(1)
Kersa and Jeldessa woredas
Jimma, Ethiopia
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06380504. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me